Alpha-1 antitrypsin for treating high-risk acute graft-versus-host disease after a haematopoietic stem cell transplant in people 12 years and over [TSID12036]

  • Awaiting development
  • GID-TA11596
  • Expected publication date: TBC

28719-Alpha-1-Antitrypsin-for-Graft-Versus-Host-Disease-V1.0-APR2024-NON-CONF.pdf (nihr.ac.uk)